CSB 2.008 Note
(av) Camazepam;
CSB 2.008 Note
(cd) Clobazam;
CSB 2.008 Note
(cg) Clotiazepam;
CSB 2.008 Note
(co) Cloxazolam;
CSB 2.008 Note
(cq) Delorazepam;
CSB 2.008 Note
(cu) Estazolam;
CSB 2.008 Note
(ed) Ethyl loflazepate;
CSB 2.008 Note
(eg) Fludiazepam;
CSB 2.008 Note
(ej) Flunitrazepam;
CSB 2.008 Note
(ep) Haloxazolam;
CSB 2.008 Note
(es) Loprazolam;
CSB 2.008 Note
(eu) Lormetazepam;
CSB 2.008 Note
(ey) Medazepam;
CSB 2.008 Note
(hh) Nimetazepam;
CSB 2.008 Note
(hj) Nitrazepam;
CSB 2.008 Note
(hk) Nordiazepam;
CSB 2.008 Note
(hr) Oxazolam;
CSB 2.008 Note
(md) Pinazepam;
CSB 2.008 Note
(ng) Tetrazepam.
CSB 2.008 Note
(31) Paragraph (eq) of s. 161.20 (2), Stats., is repealed and recreated to read:
CSB 2.008 Note
(eq) Ketazolam
CSB 2.008 Note
(32) Paragraph (o) of s. 161.20 (2), Stats., is repealed.
CSB 2.008 Note
(33) Paragraphs (ag), (ar) and (bm) of s.
161.20 (2m), Stats., are created to read:
CSB 2.008 Note
(ag) N,N-dimethyl-1,2-diphenylethylamine, commonly known as “SPA";
CSB 2.008 Note
(ar) Fencamfamine;
CSB 2.008 Note
(bm) Mazindol;
CSB 2.008 Note
(34) Paragraph (b) of s. 161.20 (4), Stats., is repealed and recreated to read:
CSB 2.008 Note
(b) Pentazocine, including its isomers and salts of isomers.
CSB 2.008 History
History:
Cr.
Register, November, 1992, No 443, eff. 12-1-92.
CSB 2.008 Note
CSB 2.22 Additions to drug schedules. (1) Paragraph (b) of s.
161.14 (2), Stats., is amended to read:
CSB 2.008 Note
(b) Alphacetylmethadol (except Levo-alphacetylmethadol (LAAM))
CSB 2.008 Note
(2) Paragraph (cm) of s.
161.14 (4), Stats., is created to read:
CSB 2.008 Note
(cm) Alpha-ethyltryptamine, its optical isomers, salts and salts of isomers;
CSB 2.008 Note
(3) Paragraph (bm) of s.
161.14 (4), Stats., is created to read:
CSB 2.008 Note
(bm) 2,5-dimethoxy-4-ethylamphetamine, commonly known as DOET;
CSB 2.008 Note
(4) Paragraph (am) of s.
161.14 (7), Stats., is created to read:
CSB 2.008 Note
(am) Aminorex, its salts, optical isomers, and salts of optical isomers;
CSB 2.008 Note
(5) Paragraph (ag) of s.
161.14 (7), Stats., is created to read:
CSB 2.008 Note
(ag) Cathinone;
CSB 2.008 Note
(6) Paragraph (gm) of s.
161.16 (3), Stats., is created to read:
CSB 2.008 Note
(gm) Levo-alphacetylmethadol (LAAM)
CSB 2.008 History
History:
Cr.
Register, August, 1994, No. 464, eff. 9-1-94.
CSB 2.008 Note
CSB 2.23 Additions and amendments to drug schedules. (1) Paragraph (wg) of s.
161.14 (4), Stats., is created to read:
CSB 2.008 Note
(wg) 4-bromo-2,5-dimethoxyphenethylamine;
CSB 2.008 Note
(7) Anabolic steroids. Unless specifically excepted under federal regulations, any compound, material, compound, mixture or preparation containing any quantity of the following anabolic steroids, including any of their esters, isomers, esters of isomers, salts and salts of esters, isomers and esters of isomers, whenever those esters, isomers, esters of isomers, salts and salts [of] esters, isomers and esters of isomers exist within the specific chemical designation:
CSB 2.008 Note
(3) Paragraph (3) (c), of s. 161.18, Stats., is repealed.
CSB 2.008 History
History:
Cr.
Register, November, 1994, No. 467, eff. 12-1-94.
CSB 2.008 Note
CSB 2.24 Addition of butorphanol to schedule IV. (1) Paragraph (c) of s.
961.20 (4), Stats., is created to read:
CSB 2.008 Note
(c) Butorphanol, including any of its isomers and salts of isomers.
CSB 2.008 History
History:
Cr.
Register, November, 1998, No. 515, eff. 12-1-98.
CSB 2.008 Note
CSB 2.25 Addition of remifentanil to schedule II; transfer of dronabinol from schedule II to schedule III; addition of fenproporex, modafinil, sibutramine, zaleplon and zolpidem to schedule IV; spelling correction of carfentanil. (1) Section
961.16 (3) (cm), Stats., is amended to read:
CSB 2.008 Note
(cm) Carfentanil;
CSB 2.008 Note
(xm) Remifentanil;
CSB 2.008 Note
(3) Section 961.16 (10) (a), Stats., is repealed.
CSB 2.008 Note
(4) Section
961.18 (4m), Stats., is created to read:
CSB 2.008 Note
(4m) Hallucinogenic substances. Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. food and drug administration approved drug product. (Other names for dronabinol are (6aR-trans)-6a, 7, 8, 10a-tetrahydro-6, 6. 9-trimethyl-3-pentyl-6H-dibenzo(b, d)pyran-1-ol, and (-)-delta-9-(trans)-tetrahydrocannabinol.)
CSB 2.008 Note
(o) Zaleplon.
CSB 2.008 Note
(p) Zolpidem.
CSB 2.008 Note
(at) Fenproporex.
CSB 2.008 Note
(bu) Modafinil.
CSB 2.008 Note
(f) Sibutramine.
CSB 2.008 History
History:
Cr.
Register, July, 2000, No. 535, eff. 8-1-00.
CSB 2.008 Note
CSB 2.26 Addition of dihydroetorphine to schedule II. (1) Section
961.16 (2) (a) 4r., Stats., is created to read:
CSB 2.008 Note
4r. Dihydroetorphine.
CSB 2.008 History
History:
CR 01-071: Cr.
Register November 2001 No. 551, eff. 12-1-01.
CSB 2.008 Note
CSB 2.28 Addition of dichloralphenazone to schedule IV. (1) Section
961.20 (2) (cs), Stats., is created to read:
CSB 2.008 History
History:
CR 02-025: Cr.
Register October 2002 No. 562, eff. 11-1-02.
CSB 2.008 Note
CSB 2.29 Transfer of buprenorphine from schedule V to schedule III. (1) Section
961.18 (5m), Stats., is created to read:
CSB 2.008 NoteSection 961.18 (5m) Narcotic Drugs Not Limited by Quantity. Any material, compound, mixture, or preparation containing any of the following narcotic drugs, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:
CSB 2.008 Note
(a) Buprenorphine
CSB 2.008 History
History:
CR 03-056: cr.
Register January 2004 No. 577, eff. 2-1-04.
CSB 2.008 Note
CSB 2.30 Addition of gamma-hydroxybutyric acid to schedule III. (1) Section
961.18 (3) (o), Stats., is created to read:
CSB 2.008 NoteSection 961.18 (3) (o) Any drug product containing gamma-hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the federal food, drug and cosmetic act:
CSB 2.008 Note
1. Gamma-hydroxybutyric acid.
CSB 2.008 History
History:
CR 03-057: cr.
Register January 2004 No. 577, eff. 2-1-04.
CSB 2.008 Note
CSB 2.31 Addition of 2,5 dimethoxy-4-(n)- propylthiophenethylamine (2C-T-7) to schedule I. (1) Section
961.14 (4) (wh), Stats., is created to read:
CSB 2.008 NoteSection 961.14 (4) (wh) 2,5 dimethoxy-4-(n)- propylthiophenethylamine, commonly known as “2C-T-7";
CSB 2.008 History
History:
CR 06-058: cr.
Register April 2007 No. 616, eff. 5-1-07.
CSB 2.008 Note
CSB 2.32 Addition of N- benzylpiperazine (BZP) to schedule I. (1) Section
961.14 (7) (q), Stats., is created to read:
CSB 2.008 NoteSection 961.14 (7) (q) N- benzylpiperazine, commonly known as “BZP."
CSB 2.008 History
History:
CR 06-058: cr.
Register April 2007 No. 616, eff. 5-1-07.
CSB 2.008 Note
CSB 2.33 Addition of alpha-methyltryptamine (AMT) to schedule I. (1) Section
961.14 (4) (wi), Stats., is created to read:
CSB 2.008 NoteSection 961.14 (4) (wi) Alpha-methyltryptamine, commonly known as “AMT";
CSB 2.008 History
History:
CR 06-059: cr.
Register April 2007 No. 616, eff. 5-1-07.
